Table 3 Statistical differences between treatments at time point 3d (day 3)
From: Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Cell line | Vemurafenib vs control | PLX4720 vs control | Sorafenib vs control |
|---|---|---|---|
MEL-2805 | P = 0.093 | P = 0.384 | P = 0.343 |
MEL-2492 | P = 0.044 | P = 0.050 | P = 0.927 |
MEL-3025 | P = 0.003 | P = 0.010 | P = 0.290 |
MEL-2523 | P = 0.087 | P = 0.220 | P = 0.369 |
MEL-3104 | P = 0.069 | P = 0.067 | P = 0.938 |